The second-generation of drug-eluting stent (DES) technology is now reality in the U.S. Medtronic (Minneapolis) in early February reported FDA approval of the Endeavor DES, making it the first in the DES 2.0 family of these devices to win marketing okay in the U.S.

Second-generation DES era opens with Endeavor approval

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR